INPP4B shRNA knockdown attenuated melanoma cell proliferation and xenograft tumour growth, whereas INPP4B overexpression enhanced cell proliferation and promoted melanocyte anchorage-independent cell growth, driven by INPP4B-mediated activation of SGK3 in an AKT-independent manner (Table 2) [143]. Here, INPP4B is linked to melanoma.